stella
beta
Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE) — Stella
Recruiting
Back to Atrium; Fibrillation trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(6 sites)
Brazil
Hospital Ana Nery, Salvador, Estado de Bahia
Instituto de Cardiologia do DF, Brasília, Federal District
Hospital Universitário Maria Aparecida Pedrossian - EBSERH, Campo Grande, Mato Grosso do Sul
Sociedade Beneficente de Senhoras Hospital Sírio-Libanês, São Paulo, São Paulo
Hospital Universitário São Francisco na Providência de Deus, Bragança Paulista
Show all 6 locations
View full record on ClinicalTrials.gov